Exact Mass: 365.0022

Exact Mass Matches: 365.0022

Found 51 metabolites which its exact mass value is equals to given mass value 365.0022, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Nifursol

2-Hydroxy-3,5-dinitro-N-[(1Z)-(5-nitrofuran-2-yl)methylidene]benzene-1-carbohydrazonate

C12H7N5O9 (365.0244)

Veterinary antiprotozoal, especially for poultr

Luxabendazole

N-{6-[(4-fluorobenzenesulphonyl)oxy]-1H-1,3-benzodiazol-2-yl}methoxycarboximidic acid

C15H12FN3O5S (365.0482)

Eudistomidin C

Eudistomidin C

C15H16BrN3OS (365.0197)

Cyto3A7

Cyto3A7

C20H13Cl2N3 (365.0486)

Maybridge3_003568

Maybridge3_003568

C16H15NO5S2 (365.0392)

3-(3,5-dibromo-4-methoxyphenyl)-2-methoxy-N-methylpropan-1-amine

3-(3,5-dibromo-4-methoxyphenyl)-2-methoxy-N-methylpropan-1-amine

C12H17Br2NO2 (364.9626)

YK-4-279

4,7-dichloro-1,3-dihydro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-2H-indole-2-one

C17H13Cl2NO4 (365.0222)

H 152/77

H 152/77

C17H13Cl2NO4 (365.0222)

Nifursol

2-Hydroxy-3,5-dinitrobenzoic acid [(5-nitro-2-furanyl)methylene]hydrazide, 9ci

C12H7N5O9 (365.0244)

C254 - Anti-Infective Agent > C258 - Antibiotic

1-chloro-N-(2-(ethylsulfonyl)-5-(trifluoromethyl)phenyl)methanesulfonamide

1-chloro-N-(2-(ethylsulfonyl)-5-(trifluoromethyl)phenyl)methanesulfonamide

C10H11ClF3NO4S2 (364.977)

2-BENZYLOXY-6-FLUOROPHENYLBORONIC ACID

2-BENZYLOXY-6-FLUOROPHENYLBORONIC ACID

C11H14BClINO2 (364.9851)

Naphthaloximidodiethyl thiophosphate

Naphthaloximidodiethyl thiophosphate

C16H16NO5PS (365.0487)

1-(4-bromo-2-phenylmethoxyphenyl)-N-phenylmethanimine

1-(4-bromo-2-phenylmethoxyphenyl)-N-phenylmethanimine

C20H16BrNO (365.0415)

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro- (6CI,7CI,8CI,9CI)

Pyrido[1,2-a]benzimidazole, 1,2,3,4-tetrahydro- (6CI,7CI,8CI,9CI)

C18H11N3O4S (365.047)

Glucantime

Meglumine antimonate

C7H18NO8Sb (365.0071)

P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01C - Agents against leishmaniasis and trypanosomiasis > P01CB - Antimony compounds D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents

3-BROMO-N-(3,3-DIETHOXY-PROPYL)-BENZENESULFONAMIDE

3-BROMO-N-(3,3-DIETHOXY-PROPYL)-BENZENESULFONAMIDE

C13H20BrNO4S (365.0296)

Bis(4-nitrophenyl) phosphorazidate

Bis(4-nitrophenyl) phosphorazidate

C12H8N5O7P (365.0161)

N-(4-benzoylphenyl)-2-iodoacetamide

N-(4-benzoylphenyl)-2-iodoacetamide

C15H12INO2 (364.9913)

5-(6-Bromonaphthalen-2-yl)-2,2-dimethyl-5-nitro-1,3-dioxane

5-(6-Bromonaphthalen-2-yl)-2,2-dimethyl-5-nitro-1,3-dioxane

C16H16BrNO4 (365.0263)

6-BROMO-5-(2-FLUORO-4-NITROPHENOXY)-1-METHYL-1H-INDAZOLE

6-BROMO-5-(2-FLUORO-4-NITROPHENOXY)-1-METHYL-1H-INDAZOLE

C14H9BrFN3O3 (364.9811)

3-ETHYL-2-METHYL-5-PHENYL-BENZOOXAZOL-3-IUM IODIDE

3-ETHYL-2-METHYL-5-PHENYL-BENZOOXAZOL-3-IUM IODIDE

C16H16INO (365.0277)

Luxabendazole

Luxalbendazole

C15H12FN3O5S (365.0482)

C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

Bis(trifluoro-2,4-pentanedionato)cobalt(II) Hydrate

Bis(trifluoro-2,4-pentanedionato)cobalt(II) Hydrate

C10H8CoF6O4 (364.9659)

Brocrinat

Brocrinat

C15H9BrFNO4 (364.9699)

C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)-N-METHOXY-N-METHYLTHIOPHENE-2-CARBOXAMIDE

3-(N-(4-CHLORO-3-METHYLISOXAZOL-5-YL)SULFAMOYL)-N-METHOXY-N-METHYLTHIOPHENE-2-CARBOXAMIDE

C11H12ClN3O5S2 (364.9907)

(2,3,4,5,6-pentafluorophenyl) 6-phenylpyridine-3-carboxylate

(2,3,4,5,6-pentafluorophenyl) 6-phenylpyridine-3-carboxylate

C18H8F5NO2 (365.0475)

C.I.Acid Brown 4

C.I.Acid Brown 4

C16H12N3NaO4S (365.0446)

3-(2-CHLORO-6-FLUOROPHENYL)-N-(2-CHLORO-3-PYRIDINYL)-5-METHYL-4-ISOXAZOLECARBOXAMIDE

3-(2-CHLORO-6-FLUOROPHENYL)-N-(2-CHLORO-3-PYRIDINYL)-5-METHYL-4-ISOXAZOLECARBOXAMIDE

C16H10Cl2FN3O2 (365.0134)

POLYSTYRENE SUPPORTED IODOBENZENE DIACETATE

POLYSTYRENE SUPPORTED IODOBENZENE DIACETATE

C12H16INO4 (365.0124)

6-Chloro-3-indolyl β-D-glucuronide sodium salt

6-Chloro-3-indolyl β-D-glucuronide sodium salt

C14H13ClNNaO7 (365.0278)

O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate

O,O-Diethylphosphoryl (Z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetate

C11H16N3O7PS (365.0447)

Foslinanib

Foslinanib

C16H13FNO6P (365.0464)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

Fenoxasulfone

Fenoxasulfone

C14H17Cl2NO4S (365.0255)

N-[4-(2,4-dichlorophenoxy)-6-(trifluoromethyl)-2-pyrimidinyl]-N-isopropylamine

N-[4-(2,4-dichlorophenoxy)-6-(trifluoromethyl)-2-pyrimidinyl]-N-isopropylamine

C14H12Cl2F3N3O (365.0309)

2-({[4-(Trifluoromethoxy)phenyl]sulfonyl}amino)ethyl Dihydrogen Phosphate

2-({[4-(Trifluoromethoxy)phenyl]sulfonyl}amino)ethyl Dihydrogen Phosphate

C9H11F3NO7PS (364.9946)

5-Monophosphate-9-beta-D-ribofuranosyl xanthine

5-Monophosphate-9-beta-D-ribofuranosyl xanthine

C10H14N4O9P+ (365.0498)

Orotidine 5-phosphate(3-)

Orotidine 5-phosphate(3-)

C10H10N2O11P-3 (365.0022)

COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

acetamidomethyl-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxyphosphinic acid

acetamidomethyl-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]oxyphosphinic acid

C8H17NO11P2 (365.0277)

1-[4-(4-Bromophenyl)-2-thiazolyl]-4-piperidinecarboxamide

1-[4-(4-Bromophenyl)-2-thiazolyl]-4-piperidinecarboxamide

C15H16BrN3OS (365.0197)

4-Cyanobenzoic acid [4-oxo-6-[(2-pyrimidinylthio)methyl]-3-pyranyl] ester

4-Cyanobenzoic acid [4-oxo-6-[(2-pyrimidinylthio)methyl]-3-pyranyl] ester

C18H11N3O4S (365.047)

N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl]-2,2-difluoroacetamide

N-[3-(1,3-benzothiazol-2-yl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl]-2,2-difluoroacetamide

C16H13F2N3OS2 (365.0468)

1-(3,4-Dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea

1-(3,4-Dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)urea

C14H9Cl2N5OS (364.9905)

3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide

3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide

C12H10F3N3O3S2 (365.0116)

5-(2,5-dichlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

5-(2,5-dichlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

C15H13Cl2N5O2 (365.0446)

5-ethyl-N-[[2-(3-pyridinyl)-4-thiazolyl]methyl]-2-thiophenesulfonamide

5-ethyl-N-[[2-(3-pyridinyl)-4-thiazolyl]methyl]-2-thiophenesulfonamide

C15H15N3O2S3 (365.0326)

ethyl 2-{[(1E)-(4,6-dioxo-2-thioxohexahydropyrimidin-5-yl)methylene]amino}-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate

ethyl 2-{[(1E)-(4,6-dioxo-2-thioxohexahydropyrimidin-5-yl)methylene]amino}-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate

C15H15N3O4S2 (365.0504)

Methyl 2-O-chlorobenzoyl-4-chloro-N-methyloxalonilate

Methyl 2-O-chlorobenzoyl-4-chloro-N-methyloxalonilate

C17H13Cl2NO4 (365.0222)

Orotidine 5-phosphate(3-)

Orotidine 5-phosphate(3-)

C10H10N2O11P (365.0022)

Trianion of orotidine 5-phosphate arising from deprotonation of carboxylic acid and phosphate functions.

BMS-986121

BMS-986121

C15H9Cl2N3O2S (364.9793)

BMS-986121 is a positive allosteric modulator (PAM) of the μ opioid receptor extracted from patent WO2014107344. BMS-986121 is built on a chemical scaffold representing a new chemotype for μ receptor PAMs[1][2][3].

5-bromo-1-[1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

5-bromo-1-[1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

C15H16BrN3OS (365.0197)

5-bromo-1-[(1s)-1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

5-bromo-1-[(1s)-1-(methylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

C15H16BrN3OS (365.0197)